Chitosan-based nanoparticles as delivery-carrier for promising antimicrobial glycolipid biosurfactant to improve the eradication rate of Helicobacter pylori biofilm

References

• Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther. 1995;9(Suppl. 2):33–39.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Fujisaki J, Omae M, et al. Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings. Dig Endosc. 2015;27(5):551–561.
   PubMed Web of Science ®Google Scholar
• Mehmood K, Awan AA, Muhammad N, et al. Helicobacter pylori prevalence and histopathological findings in dyspeptic patients. J Ayub Med Coll Abbottabad. 2014;26(2):182–185.
   PubMedGoogle Scholar
• Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol. 2002;292(2):107–113.
   PubMed Web of Science ®Google Scholar
• Vyas SP, Sihorkar V, Jain S. Mannosylated liposomes for bio-film targeting. Int J Pharm. 2007;330(1-2):6–13.
   PubMed Web of Science ®Google Scholar
• Cammarota G, Sanguinetti M, Gallo A, et al. Review article: biofilm formation by Helicobacter pylori as a target for eradication of resistant infection. Aliment Pharmacol Ther. 2012;36(3):222–230.
   PubMed Web of Science ®Google Scholar
• Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318–1322.
   PubMed Web of Science ®Google Scholar
• Pamp SJ, Gjermansen M, Johansen HK, et al. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol Microbiol. 2008;68(1):223–240.
   PubMed Web of Science ®Google Scholar
• Penesyan A, Gillings M, Paulsen IT. Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities. Molecules. 2015;20(4):5286–5298.
   PubMed Web of Science ®Google Scholar
• Hobley L, Harkins C, MacPhee CE, et al. Giving structure to the biofilm matrix: an overview of individual strategies and emerging common themes. FEMS Microbiol Rev. 2015;39(5):649–669.
   PubMed Web of Science ®Google Scholar
• Hoiby N, Bjarnsholt T, Givskov M, et al. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35(4):322–332.
   PubMed Web of Science ®Google Scholar
• Jensen ET, Kharazmi A, Lam K, et al. Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms. Infect Immun. 1990;58(7):2383–2385.
   PubMed Web of Science ®Google Scholar
• Domenech M, Ramos-Sevillano E, García E, et al. Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae. Infect Immun. 2013;81(7):2606–2615.
   PubMed Web of Science ®Google Scholar
• Chen LM, Xu YH, Zhou CL, et al. Overexpression of CDR1 and CDR2 genes plays an important role in fluconazole resistance in Candida albicans with G487T and T916C mutations. J Int Med Res. 2010;38(2):536–545.
   PubMed Web of Science ®Google Scholar
• Anwar H, Dasgupta MK, Costerton JW. Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob Agents Chemother. 1990;34(11):2043–2046.
   PubMed Web of Science ®Google Scholar
• Ribeiro IA, Castro MF, Ribeiro MH. Sophorolipids: production, characterization and biologic activity in applications of microbial engineering. In: Gupta VK, Schmoll M, Maki M, Tuohy M, Mazutti MA, editors. Applications of Microbial Engineering. Boca Raton: CRC Press; 2013a. p. 367–407.
   Google Scholar
• Bharali P, Saikia JP, Ray A, et al. Rhamnolipid (RL) from Pseudomonas aeruginosa OBP1: a novel chemotaxis and antibacterial agent. Colloids Surf B Biointerfaces. 2013;103:502–509.
   PubMed Web of Science ®Google Scholar
• Silveira VAI, Nishio EK, Freitas CAUQ, et al. Production and antimicrobial activity of sophorolipid against Clostridium perfringens and Campylobacter jejuni and their additive interaction with lactic acid. Biocat Agric Biotechnol. 2019;21:101287.
   Web of Science ®Google Scholar
• Pontes C, Alves M, Santos C, et al. Can Sophorolipids prevent biofilm formation on silicone catheter tubes? Int J Pharm. 2016;513(1-2):697–708.
   PubMedGoogle Scholar
• Forier K, Raemdonck K, De Smedt SC, et al. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms. J Control Release. 2014;190:607–623.
   PubMed Web of Science ®Google Scholar
• Cheow WS, Hadinoto K. Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles. Particuology. 2012;10(3):327–333.
   Web of Science ®Google Scholar
• Bhattacharya M, Wozniak DJ, Stoodley P, et al. Prevention and treatment of Staphylococcus aureus biofilms. Expert Rev Anti Infect Ther. 2015;13(12):1499–1516.
   PubMed Web of Science ®Google Scholar
• Hadidi M, Pouramin S, Adinepour F, et al. Chitosan nanoparticles loaded with clove essential oil: characterization, antioxidant and antibacterial activities. Carbohydr Polym. 2020;236:116075.
   PubMed Web of Science ®Google Scholar
• Pan C, Qian J, Zhao C, et al. Study on the relationship between crosslinking degree and properties of TPP crosslinked chitosan nanoparticles. Carbohydr Polym. 2020;241:116349.
   PubMed Web of Science ®Google Scholar
• Inès M, Dhouha G. Glycolipid biosurfactants: potential related biomedical and biotechnological applications. Carbohydr Res. 2015;416:59–69.
   PubMed Web of Science ®Google Scholar
• Cadete A, Figueiredo L, Lopes R, et al. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles. Eur J Pharm Sci. 2012;45(4):451–458.
   PubMed Web of Science ®Google Scholar
• Martin V, Ribeiro IAC, Alves MM, et al. Understanding intracellular trafficking and anti-inflammatory effects of minocycline chitosan-nanoparticles in human gingival fibroblasts for periodontal disease treatment. Int J Pharm. 2019;572:118821.
   PubMedGoogle Scholar
• Arif M, Raja MA, Zeenat S, et al. Preparation and characterization of polyelectrolyte complex nanoparticles based on poly (malic acid), chitosan. A pH-dependent delivery system. J Biomater Sci Polym Ed. 2017;28(1):50–62.
   PubMed Web of Science ®Google Scholar
• Lawrie G, Keen I, Drew B, et al. Interactions between alginate and chitosan biopolymers characterized using FTIR and XPS. Biomacromolecules. 2007;8(8):2533–2541.
   PubMed Web of Science ®Google Scholar
• Kumirska J, Czerwicka M, Kaczyński Z, et al. Application of spectroscopic methods for structural analysis of chitin and chitosan. Mar Drugs. 2010;8(5):1567–1636.
   PubMed Web of Science ®Google Scholar
• Leitermann F, Syldatk C, Hausmann R. Fast quantitative determination of microbial rhamnolipids from cultivation broths by ATR-FTIR Spectroscopy. J Biol Eng. 2008;2:1–8.
   PubMedGoogle Scholar
• Rahman PKSM, Pasirayi G, Auger V, et al. Production of rhamnolipid biosurfactants by Pseudomonas aeruginosa DS10-129 in a microfluidic bioreactor. Biotechnol Appl Biochem. 2010;55(1):45–52.
   PubMedGoogle Scholar
• Abdelgawad AM, Hudson SM. Chitosan nanoparticles: polyphosphates cross-linking and protein delivery properties. Int J Biol Macromol. 2019;136:133–142.
   PubMed Web of Science ®Google Scholar
• Garrido-Maestu A, Ma Z, Paik SYR, et al. Engineering of chitosan-derived nanoparticles to enhance antimicrobial activity against foodborne pathogen Escherichia coli O157:H7. Carbohydr Polym. 2018;197:623–630.
   PubMed Web of Science ®Google Scholar
• Arif M, Dong QJ, Raja MA, et al. Development of novel pH-sensitive thiolated chitosan/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pylori. Mater Sci Eng C Mater Biol Appl. 2018;83:17–24.
   PubMed Web of Science ®Google Scholar
• Raafat D, Von Bargen K, Haas A, et al. Insights into the mode of action of chitosan as an antibacterial compound. Appl Environ Microbiol. 2008;74(12):3764–3773.
   PubMed Web of Science ®Google Scholar
• Nagpal K, Singh SK, Mishra DN. Formulation, optimization, in vivo pharmacokinetic, behavioral and biochemical estimations of minocycline loaded chitosan nanoparticles for enhanced brain uptake. Chem Pharm Bull (Tokyo). 2013;61(3):258–272.
   PubMed Web of Science ®Google Scholar
• Kucukoglu V, Uzuner H, Kenar H, et al. In vitro antibacterial activity of ciprofloxacin loaded chitosan microparticles and their effects on human lung epithelial cells. Int J Pharm. 2019;569:118578.
   PubMedGoogle Scholar
• Yonezawa H, Osaki T, Hanawa T, et al. Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations. PLoS One. 2013;8(9):e73301.
   PubMed Web of Science ®Google Scholar
• Xie Y, Xie ZX, Zhou NJ. The study on anti-Helicobacter pylori mechanisms of chitosans in vitro. Chin J Dig. 2004;24(11):655–658.
   Google Scholar
• Messiaen AS, Forier K, Nelis H, et al. Transport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilms. PLoS One. 2013;8(11):e79220.
   PubMed Web of Science ®Google Scholar
• Baelo A, Levato R, Julian E, et al. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections. J Control Release. 2015;209:150–158.
   PubMed Web of Science ®Google Scholar
• Bhattacharjee A, Nusca TD, Hochbaum AI. Rhamnolipids mediate an interspecies biofilm dispersal signaling pathway. ACS Chem Biol. 2016;11(11):3068–3076.
   PubMed Web of Science ®Google Scholar
• Du MP, Xu D, Trinh XT, et al. EPS solubilization treatment by applying the biosurfactant rhamnolipid to reduce clogging in constructed wetlands. Bioresour Technol. 2016;218:833–841.
   PubMed Web of Science ®Google Scholar
• Dusane DH, Nancharaiah YV, Zinjarde SS, et al. Rhamnolipid mediated disruption of marine Bacillus pumilus biofilms. Colloids Surf B Biointerfaces. 2010;81(1):242–248.
   PubMed Web of Science ®Google Scholar
• Hadrup N, Lam HR. Oral toxicity of silver ions, silver nanoparticles and colloidal silver-a review. Regul Toxicol Pharmacol. 2014;68(1):1–7.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Dai XM, Wei XS, et al. Near-infrared light-activated thermosensitive liposomes as efficient agents for photothermal and antibiotic synergistic therapy of bacterial biofilm. ACS Appl Mater Interfaces. 2018;10(17):14426–14437.
   PubMed Web of Science ®Google Scholar
• Wolfmeier H, Pletzer D, Mansour SC, et al. New perspectives in biofilm eradication. ACS Infect Dis. 2018;4(2):93–106.
   PubMed Web of Science ®Google Scholar
• Dusane DH, Dam S, Nancharaiah YV, et al. Disruption of Yarrowia lipolytica biofilms by rhamnolipid biosurfactant. Aquat Biosyst. 2012;8(1):17.
   PubMedGoogle Scholar
• Costa EM, Silva S, Vicente S, et al. Chitosan nanoparticles as alternative anti-staphylococci agents: bactericidal, antibiofilm and antiadhesive effects. Mater Sci Eng C Mater Biol Appl. 2017;79:221–226.
   PubMed Web of Science ®Google Scholar
• Isabel Azcurra A, Bojanich SRB, Calamari MA, et al. Effect of the high molecular weight chitosan and sodium alginate on Candida albicans hydrophobicity and adhesion to cells. Med Oral Patol Oral. 2006;2(11):E120–E125.
   Google Scholar
• Nickzad A, Deziel E. The involvement of rhamnolipids in microbial cell adhesion and biofilm development - an approach for control? Lett Appl Microbiol. 2014;58(5):447–453.
   PubMed Web of Science ®Google Scholar
• Stunova A, Vistejnova L. Dermal fibroblasts - a heterogeneous population with regulatory function in wound healing. Cytokine Growth Factor Rev. 2018;39:137–150.
   PubMed Web of Science ®Google Scholar
• Bautista-Hernández LA, Gómez-Olivares JL, Buentello-Volante B, et al. Fibroblasts: the unknown sentinels eliciting immune responses against microorganisms. Eur J Microbiol Immunol (Bp). 2017;7(3):151–157.
   PubMedGoogle Scholar